Linda De Young

Linda bridges the connection between technology and drug development at NuMedii. She brings 20 years of experience leading drug development programs for industry-leading and start-up biotechnology and life science companies across a variety of platforms – small molecule, protein, polymer, cellular, and antisense therapeutics – as well as a range of drug delivery devices. In addition to 10 years as a principal at Virtualizing Drug Development and IND Enabling Consulting, Linda held senior leadership positions at several companies focused on cardiovascular disease and oncology including AeroGen and Genentech. Linda has a BS in Biochemistry from UC Davis, a Ph.D. in Pharmaceutical Chemistry from UC San Francisco, and was a Postdoctoral Fellow, at the Department of Chemistry and Biochemistry, UC Santa Cruz.